Bone Cancer Archives - Page 3 of 28 - Cancer Therapy Advisor

Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers in adoption of genetic testing

Genomics Industry Tries New Strategies to Engage Community Oncologists

By

May 21, 2020

Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers to adoption of genetic testing.

The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated.

General Oncology

A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials

By

Caroline Seydel

May 13, 2020

The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated.

Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.

General Oncology

Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer

By

Sarah Elizabeth Richards

May 7, 2020

Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.

General Oncology

Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation

By

Julia Faith Sklar

March 24, 2020

The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.

Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.

General Oncology

“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19

By

Agata Boxe

March 17, 2020

Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.

A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate.

General Oncology

Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data

By

Christina Bennett, MS

March 11, 2020

A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate.

CRISPR-modified T cells were used in 3 patients with advanced cancer for the first time, showing modest results on tumor growth.

General Oncology

First Human Clinical Trial in US to Test the Use of CRISPR-Modified T Cells in Cancer Answers Vital Questions

By

Victoria Forster, PhD

March 5, 2020

CRISPR-modified T cells were used in 3 patients with advanced cancer for the first time, showing modest results on tumor growth.

Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.

General Oncology

Improving Cancer Pain Management Amid the Opioid Crisis

By

Liz Seegert

March 3, 2020

Research into opioid alternatives for cancer-related pain has stalled, however substance use disorders remain problematic.

Drug companies are gathering and including expanded access data in drug submissions as real-world data, but the purpose of expanded access was never for the purpose of research.

General Oncology

A New Trend in Drug Development: Leveraging Data from Expanded Access

By

Christina Bennett, MS

March 2, 2020

Drug companies are gathering and including expanded access data in drug submissions as real-world data, but the purpose of expanded access was never for the purpose of research.

New research shows that B cells — and not just T cells — influence whether patients respond to immunotherapy in melanoma, sarcoma, and kidney cancers.

General Oncology

Evidence Suggests B Cells Play a Role in Immunotherapy Response

By

Sarah Elizabeth Richards

February 24, 2020

New research shows that B cells — and not just T cells — influence whether patients respond to immunotherapy in melanoma, sarcoma, and kidney cancers.